|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0011923,
umls-concept:C0032743,
umls-concept:C0087111,
umls-concept:C0392762,
umls-concept:C0521425,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2006-6-19
|
|
pubmed:abstractText |
In breast cancer, [(18)F]fluoroestradiol (FES) positron emission tomography (PET) correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We tested the ability of FES-PET imaging to predict response to salvage hormonal treatment in heavily pretreated metastatic breast cancer patients, predominantly treated with aromatase inhibitors.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:DunnwaldLisa KLK,
pubmed-author:EllisGeorgiana KGK,
pubmed-author:GralowJulie RJR,
pubmed-author:KrohnKenneth AKA,
pubmed-author:LindenHannah MHM,
pubmed-author:LinkJeanne MJM,
pubmed-author:LivingstonRobert BRB,
pubmed-author:MankoffDavid ADA,
pubmed-author:PetersonLanell MLM,
pubmed-author:PetraPhilip HPH,
pubmed-author:SchubertErin KEK,
pubmed-author:StekhovaSvetlana ASA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2793-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16682724-Adult,
pubmed-meshheading:16682724-Aged,
pubmed-meshheading:16682724-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16682724-Aromatase Inhibitors,
pubmed-meshheading:16682724-Bone Neoplasms,
pubmed-meshheading:16682724-Breast Neoplasms,
pubmed-meshheading:16682724-Estradiol,
pubmed-meshheading:16682724-Female,
pubmed-meshheading:16682724-Fluorine Radioisotopes,
pubmed-meshheading:16682724-Humans,
pubmed-meshheading:16682724-Male,
pubmed-meshheading:16682724-Middle Aged,
pubmed-meshheading:16682724-Positron-Emission Tomography,
pubmed-meshheading:16682724-Radiopharmaceuticals,
pubmed-meshheading:16682724-Receptors, Estrogen,
pubmed-meshheading:16682724-Salvage Therapy,
pubmed-meshheading:16682724-Tamoxifen
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
|
|
pubmed:affiliation |
Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. hmlinden@u.washington.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
